Khalid Usman, et al. “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 28, no. 2, July 2021, pp. 418-22, https://doi.org/10.53555/jptcp.v28i2.6807.